The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.
Researchers found that breast-conserving treatment provided long-term survival outcomes comparable to mastectomy in patients with breast cancer and BRCA1 or BRCA2 pathogenic variants.
Total neoadjuvant therapy was shown to be less effective for treating patients with rectal cancer with inflammatory bowel disease (IBD) than those with sporadic rectal cancer, according to study findi...
A new multinational study found that removing the full extent of noncontrast-enhanced tumor seen on MRI scans led to significantly longer survival in patients with IDH wild-type glioblastoma.
Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A large French clinical trial found that patients with moderate to severe ARDS who received sevoflurane had fewer ventilator-free days and lower 90-day survival than those sedated with propofol.
Glaucoma specialist Inder Paul Singh outlines the precision and versatility of the VIA360™ Surgical System for the delivery of viscoelastic fluid during ophthalmic surgery
A rare case of pneumomediastinum and subcutaneous emphysema following dental cleaning requires high-flow oxygen therapy rather than invasive interventions. Learn why.